|
Real-time Estimate
Cboe BZX
11:39:01 2026-09-11 am EDT
|
5-day change | 1st Jan Change | ||
| 501.94 USD | -0.91% |
|
-6.21% | -25.77% |
| Aug. 17 | IDEXX Laboratories, Inc. - Analyst/Investor Day | |
| Aug. 11 | IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment | MT |
| Market Cap | 39.9B 34.32B 32.38B 29.5B 55.14B 3,815B 55.64B 386B 148B 1,935B 150B 147B 6,147B | P/E 2026 * |
34.3x | P/E 2027 * | 30.3x |
|---|---|---|---|---|---|
| Enterprise Value | 40.27B 34.63B 32.68B 29.77B 55.65B 3,850B 56.16B 389B 150B 1,953B 151B 148B 6,203B | EV / Sales 2026 * |
8.52x | EV / Sales 2027 * | 7.74x |
| Free-Float |
72.37% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IDXX | Delayed | |
CBOE
| IDXX | Real-time | |
London S.E.
| 0J8P | Delayed | |
Tradegate
| IX1 | Real-time | |
Börse Stuttgart
| IX1 | Delayed | |
Mexican S.E.
| IDXX * | End-of-day quote | |
Boerse Muenchen
| IX1 | Real-time | |
Wiener Boerse
| IDXX | End-of-day quote | |
Deutsche Boerse AG
| IX1 | Delayed | |
Xetra
| IX1 | Delayed | |
Berne S.E.
| IX1 | End-of-day quote | |
Borsa Italiana
| 1IDXX | End-of-day quote |
Last Transcript : IDEXX Laboratories, Inc.
| 1 day | -0.91% | ||
| 1 week | -6.21% | ||
| Current month | -9.80% | ||
| 1 month | -14.40% | ||
| 3 months | -9.99% | ||
| 6 months | -16.38% | ||
| Current year | -25.77% |
| 1 week | 500.61 | 529.02 | |
| 1 month | 500.61 | 584.15 | |
| Current year | 500.61 | 726.41 | |
| 1 year | 500.61 | 769.98 | |
| 3 years | 356.14 | 769.98 | |
| 5 years | 317.06 | 769.98 | |
| 10 years | 102.45 | 769.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Erickson
CEO | Chief Executive Officer | 52 | 2026-05-11 |
Andrew Emerson
DFI | Director of Finance/CFO | 43 | 2025-02-28 |
Martin Smith
COO | Chief Operating Officer | 58 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 2026-05-11 | |
| Director/Board Member | 64 | 2013-07-14 | |
Daniel Junius
BRD | Director/Board Member | 73 | 2014-03-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/4/26 | Exercice | Director | 6,609 | 0.0084% | ||
| 8/20/26 | Exercice | Chief Financial Officer | 616 | 0.0008% | ||
| 7/30/26 | Free | Director | 49 | 0.0001% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.72B 4.06B 3.83B 3.49B 6.53B 452B 6.59B 45.65B 17.57B 229B 17.74B 17.35B 728B | 5.14B 4.42B 4.17B 3.8B 7.1B 491B 7.17B 49.67B 19.12B 249B 19.3B 18.88B 792B |
| Net income | 1.18B 1.01B 956M 871M 1.63B 113B 1.64B 11.39B 4.38B 57.16B 4.43B 4.33B 182B | 1.31B 1.13B 1.07B 972M 1.82B 126B 1.83B 12.7B 4.89B 63.74B 4.94B 4.83B 202B |
| Net Debt | 368M 316M 299M 272M 509M 35.18B 513M 3.56B 1.37B 17.85B 1.38B 1.35B 56.68B | -97.34M -83.71M -78.98M -71.95M -135M -9.31B -136M -941M -362M -4.72B -366M -358M -14.99B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | $502.16 | -0.86% | 72,214 |
| 26-09-10 | $506.53 | -1.67% | 422,340 |
| 26-09-09 | $515.15 | -0.97% | 556,503 |
| 26-09-08 | $520.21 | -2.83% | 613,034 |
| 26-09-04 | $535.38 | +1.15% | 407,845 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IDXX Stock
Select your edition
All financial news and data tailored to specific country editions

















